Neoadjuvant Adebrelimab combined with Recatisibiumab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A randomized,dual-cohort, exploratory phase 2 trial

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 5a333b89040d29b05616b823831d353212685def
First added on: Apr 22, 2026